EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PGE 2 expression by HPV6/11‐induced respiratory papillomas blocks NK cell activation in patients with recurrent respiratory papillomatosis

Mohd Israr, Fung Lam, James DeVoti, Emily M Mace, Christopher Papayannakos, Allan Abramson, Bettie M Steinberg, Vincent R Bonagura

European Journal of Immunology · 2023

DOI: 10.1002/eji.202250036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Mohd Israr und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Respiratory Tract Infections, Papilloma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDCR NIH HHS, NIAID NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent respiratory papillomatosis (RRP), a rare chronic disease caused primarily by human papillomavirus types 6 and 11, consists of repeated growth of premalignant papillomas in the airway. RRP is characterized by multiple abnormalities in innate and adaptive immunity. Natural killer (NK) cells play important roles in immune surveillance and are part of the innate immune responses that help prevent tumor growth. We identified that papillomas lack classical class I MHC and retain nonclassical class I MHC expression. Moreover, in this study, we have identified and characterized the mechanism that blocks NK cell targeting of papilloma cells. Here, we show for the first time that the PGE 2 secreted by papilloma cells directly inhibits NK cells activation/degranulation principally through the PGE 2 receptor EP2, and to a lesser extent through EP4 signaling. Thus, papilloma cells have a potent mechanism to block NK cell function that likely supports papilloma cell growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsRespiratory Tract InfectionsPapillomaHumansDinoprostoneKiller Cells, Natural

Stichwörter der Autor:innen

HPV6/11NK cell activation/degranulationPGE2PGE2 receptorsRecurrent respiratory papillomatosis

Substanzen

Dinoprostone

Autor:innen und Institutionen

  • The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
  • Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia Medical Center, NY, USA.

Förderung

  • NIDCR NIH HHS
  • NIAID NIH HHS
  • National Institute of Dental and Craniofacial Research
  • National Institutes of Health

Zitieren

APA

Israr, M., Lam, F., DeVoti, J., Mace, E. M., Papayannakos, C., Abramson, A., Steinberg, B. M., & Bonagura, V. R. (2023). PGE 2 expression by HPV6/11‐induced respiratory papillomas blocks NK cell activation in patients with recurrent respiratory papillomatosis. European Journal of Immunology. https://doi.org/10.1002/eji.202250036

Vancouver

Israr M, Lam F, DeVoti J, Mace EM, Papayannakos C, Abramson A, et al. PGE 2 expression by HPV6/11‐induced respiratory papillomas blocks NK cell activation in patients with recurrent respiratory papillomatosis. European Journal of Immunology. 2023. doi:10.1002/eji.202250036

BibTeX
@article{Israr2023,
  author = {Israr, Mohd and Lam, Fung and DeVoti, James and Mace, Emily M and Papayannakos, Christopher and Abramson, Allan and Steinberg, Bettie M and Bonagura, Vincent R},
  title = {PGE 2 expression by HPV6/11‐induced respiratory papillomas blocks NK cell activation in patients with recurrent respiratory papillomatosis},
  journal = {European Journal of Immunology},
  year = {2023},
  doi = {10.1002/eji.202250036}
}
Kostenlos starten →